US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 4.520
  • +0.200+4.63%
Trading Mar 4 13:31 ET
213.46MMarket Cap-3.60P/E (TTM)

About Silence Therapeutics Company

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.

Company Profile

SymbolSLN
Company NameSilence Therapeutics
Founded1994
CEOMr. Craig A. Tooman
MarketNASDAQ
Employees109
Securities TypeDR
ADS Ratio1.0 : 3.0
Fiscal Year Ends12-31
Address72 Hammersmith Road
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW14 8TH
Phone44-20-3457-6900
Websitehttp://www.silence-therapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Craig A. Tooman
  • President, Chief Executive Officer and Director
  • 7.30M
  • Rhonda L. Hellums
  • Chief Financial Officer and Principal Accounting Officer
  • 2.50M
  • Iain Gladstone Ross
  • Non-Executive Chairman of the Board
  • 402.00K
  • James Lawrence Ede-Golightly
  • Independent Director
  • 182.00K
  • Dr. Michael Harvey Davidson, M.D.
  • Independent Director
  • 178.00K
  • David Jakob Lemus
  • Independent Director
  • 184.00K
  • Dr. Steven Joseph Romano, M.D.
  • Head of Research and Development
  • 1.73M

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Jiangsu Changyou Environmental Protection Technology
301557
+211.60%
Hefei conver Holding
603409
+110.13%
LIERDA
832149
+30.00%
4
SHENGNAN TECHNOLOGY
837006
+29.98%
5
CHK
831167
+29.97%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
As China's 'two sessions' approach: How will Chinese stocks perform?
🎙️Discussion 1. With China's 'two sessions' approaching, do you focus more on policy dynamics or capital flows? 2. Which industry sectors d Show More
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.